Cattabeni F - Search Results

1

Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.

Padovani A, Borroni B, Colciaghi F, Pettenati C, Cottini E, Agosti C, Lenzi GL, Caltagirone C, Trabucchi M, Cattabeni F, Di Luca M. Padovani A, et al. Among authors: cattabeni f. Arch Neurol. 2002 Jan;59(1):71-5. doi: 10.1001/archneur.59.1.71. Arch Neurol. 2002. PMID: 11790233

2

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.

Borroni B, Colciaghi F, Pastorino L, Archetti S, Corsini P, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Among authors: cattabeni f. Eur Neuropsychopharmacol. 2002 Jun;12(3):195-200. doi: 10.1016/s0924-977x(02)00013-5. Eur Neuropsychopharmacol. 2002. PMID: 12007670

3

High cholesterol affects platelet APP processing in controls and in AD patients.

Borroni B, Colciaghi F, Lenzi GL, Caimi L, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Among authors: cattabeni f. Neurobiol Aging. 2003 Sep;24(5):631-6. doi: 10.1016/s0197-4580(02)00190-2. Neurobiol Aging. 2003. PMID: 12885570

4

Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study.

Borroni B, Colciaghi F, Caltagirone C, Rozzini L, Broglio L, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Among authors: cattabeni f. Arch Neurol. 2003 Dec;60(12):1740-4. doi: 10.1001/archneur.60.12.1740. Arch Neurol. 2003. PMID: 14676049

5

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.

Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M. Colciaghi F, et al. Among authors: cattabeni f. Mol Med. 2002 Feb;8(2):67-74. Mol Med. 2002. PMID: 12080182 Free PMC article.

6

Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts.

Colciaghi F, Borroni B, Zimmermann M, Bellone C, Longhi A, Padovani A, Cattabeni F, Christen Y, Di Luca M. Colciaghi F, et al. Among authors: cattabeni f. Neurobiol Dis. 2004 Jul;16(2):454-60. doi: 10.1016/j.nbd.2004.03.011. Neurobiol Dis. 2004. PMID: 15193301

7

Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease.

Cattabeni F, Colciaghi F, Di Luca M. Cattabeni F, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Aug;28(5):763-70. doi: 10.1016/j.pnpbp.2004.05.022. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15363602 Review.

8

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.

Zimmermann M, Borroni B, Cattabeni F, Padovani A, Di Luca M. Zimmermann M, et al. Among authors: cattabeni f. Neurobiol Dis. 2005 Jun-Jul;19(1-2):237-42. doi: 10.1016/j.nbd.2005.01.002. Neurobiol Dis. 2005. PMID: 15837579

9

SAP97-mediated local trafficking is altered in Alzheimer disease patients' hippocampus.

Marcello E, Epis R, Saraceno C, Gardoni F, Borroni B, Cattabeni F, Padovani A, Di Luca M. Marcello E, et al. Among authors: cattabeni f. Neurobiol Aging. 2012 Feb;33(2):422.e1-10. doi: 10.1016/j.neurobiolaging.2010.09.015. Epub 2010 Oct 27. Neurobiol Aging. 2012. PMID: 20980075 Free article.

10

Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.

Zimmermann M, Gardoni F, Marcello E, Colciaghi F, Borroni B, Padovani A, Cattabeni F, Di Luca M. Zimmermann M, et al. Among authors: cattabeni f. J Neurochem. 2004 Sep;90(6):1489-99. doi: 10.1111/j.1471-4159.2004.02680.x. J Neurochem. 2004. PMID: 15341532 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters